Alabama Senate Committee Unanimously Passes Bill to Decriminalize Marijuana Possession

Legislation to decriminalize the possession of personal amounts of marijuana has been passed unanimously by an Alabama Senate committee.

The Senate Judiciary Committee recently voted 11 to 0 to pass the marijuana decriminalization bill, sending it towards a vote by the full Senate. The vote marks a massive shift increase in support from just last year, when the committee passed the measure 6 to 4 (though it eventually stalled in the House). If passed by the full Senate, the measure would then need to pass the House of Representatives before it can be sent to Governor Kay Ivey (R) for consideration.

Under the proposed law, those caught possessing no more than an ounce of marijuana would be hit with, at most, a $250 fine for the first two offenses, and a $500 fine for subsequent offenses. As noted by Marijuana Moment, possession of more than an ounce but less than two ounces would be considered a class A misdemeanor, while possession of more than two ounces would be a class C felony, punishable by up to 10 years in prison.

Continue reading

Washington State Senate Passes Bill to Allow Students to Use Medical Marijuana on School Property

Legislation to allow parents to administer limited forms of marijuana to their children on school property has passed the state Senate, along with a proposal for new marijuana testing rules.

CBD tincture.

Both Democratic and Republican lawmakers described the school bill as aimed at students that need medical marijuana for relief from chronic illnesses, reports the Associated Press. The bill would allow marijuana-infused products, but specifically bans smoking pot and products high in the psychoactive chemical THC. Instead, lawmakers said the bill was oriented toward allowing marijuana bred for its medicinal properties, including strains high in the non-intoxicating chemical CBD.

“THC is what recreational users use to get high,” said Republican Sen. Ann Rivers of La Center. “You could eat CBD all day long and never cop a buzz.”

Continue reading

Study: Marijuana May Increase Woman’s Desire and Orgasms During Sex

According to a new study published by the journal Sexual Medicine, roughly a third of U.S. women have used marijuana before sex, and those who do report increased desire and better orgasms.

sexThe study states that marijuana use has been on the rise among U.S. adults as a growing number of states pass laws legalizing it for medical and recreational purposes. Although marijuana is thought to act on the cannabinoid receptor in the brain, which is involved in sexual function, little research to date has examined the drug’s impact on sexual health, the study team notes.

According to Reuters, researchers surveyed 373 female patients at an obstetrics and gynecology practice in an academic medical center in Saint Louis, Missouri. Overall, 127 women, or 34 percent, reported using marijuana before sexual activity.

Continue reading

Bipartisan STATES Act Reintroduced, Would Limit Federal Government’s Ability To Interfere State-Legal Marijuana Businesses

The STATES Act, which would protect marijuana businesses which are legal under their state’s law, has been reintroduced in the United States Congress.,

Senators Elizabeth Warren (D-MA) and Cory Gardner (R-CO), along with Representatives David Joyce (R-OH) and Earl Blumenauer (D-OR), have reintroduced The Strengthening the Tenth Amendment Through Entrusting States (STATES) Act of 2019, reports NORML. This Act amends the Controlled Substances Act to reduce the number of instances in which federal law enforcement agencies could carry out legal actions against state-licensed cannabis businesses or other related enterprises.

“The majority of states now regulate either the medical use or the adult use of marijuana. It is time for the federal government to cease standing in the way of these voter-backed regulatory policies being implemented throughout the country,” said NORML Political Director Justin Strekal. “Ultimately, however, we must remove marijuana from the federal Controlled Substances Act entirely in order to allow those in legal states to ultimately be free from undue federal discrimination and the fear of federal prosecution.”

Continue reading

Marijuana Associated With Fewer Disease-Related Complications In Those With Crohn’s Disease, Finds Study

According to a study published in the journal Digestive Diseases and Sciences, marijuana consumers with Crohn’s disease who are seeking hospitalization possess fewer disease-related complications compared to those who don’t use cannabis.

For the study a team of investigators from the John H. Stroger Hospital in Chicago, the SUNY Downstate Medical Centre in New York City, and the Digestive Disease Institute in Cleveland assessed the relationship between cannabis use and the prevalence of Crohn’s disease-related complications and clinical outcomes in a nationwide cohort of hospitalized patients.

According to a NORML news release, authors reported that patients with a history of cannabis use possessed fewer complications and experienced better clinical outcomes as compared to abstainers.

Continue reading

Colorado Governor Signs Bill Adding Autism Spectrum Disorder to Medical Marijuana Program

Colorado Governor Jared Polis has signed into law legislation that allows those with autism spectrum disorder to become legal medical marijuana patients.

“OK kids, that’s how we make a law,” Governor Polis said after signing House Bill 1028 into law. The measure was passed unanimously by both the House of Representatives and Senate (combined the vote was 96 to 0).

Under the new law, autism spectrum disorder joins the following qualifying medical cannabis conditions:

  • Cancer
  • Glaucoma
  • HIV or AIDS
  • Cachexia
  • Persistent muscle spasms
  • Seizures
  • Severe nausea
  • Severe pain
  • Post Traumatic Stress Disorder (PTSD)

Continue reading

Florida Legislation Would Limit THC of Medical Marijuana

A Florida bill would limit the THC percentage in smokeable medical marijuana, and would make it harder for sick children to obtain the medicine, reports the Orlando Sentinel.

The legislation was introduced by Representative Ray Rodrigues, who is the Chairman for the House Health and Human Services Committee. The measure would also set limits on the potency of medical marijuana in edibles and would fast-track the state health department’s rule making for the medical marijuana industry, which was legalized by voters in 2016.

“While the House bill would set what many consider a low cap of 10 percent on the level of THC in whole-flower products for smoking, the daily amount of THC that would be permitted in edible products — 7,000 mg for a 35-day supply, or 200 mg per day — is much higher than what most patients would consume, according to industry experts”, reports the Sentinel.

Continue reading

Federal Legislation to Allow Banks to Work with State-Legal Marijuana Businesses Advances in the House

Federal legislation that would allow banks and other financial institutions to provide services to marijuana businesses that are legal under their state’s law has been passed by a key House panel.

According to Reuters, the bill would provide sought-after clarity to banks across the country that want to do business with the growing marijuana industry, where companies have struggled to gain access to the financial system. The issue is especially relevant now that 10 states in the U.S. have legalized marijuana for recreational purposes; over 30 have passed some form of medical marijuana legalization.

The measure was broadly backed by a mixture of Democrats and Republicans. It now proceeds to the full House, where it is expected to be passed by the Democrat-led chamber in the near future. However, the bill faces an uncertain future in the Republican-led Senate, according to analysts.

Continue reading

Study: Washington Teens Not Using More Marijuana Following Legalization

The legalization of marijuana in Washington State is not associated with an increase in marijuana use by most teens, according to a study published in The Journal of Adolescent Health.

For the study researchers from Washington State University, the University of Massachusetts, and the Colorado School of Public Health assessed trends in teen marijuana use and employment in the years immediately prior to and immediately following the enactment of retail marijuana sales (2010 to 2016), reports NORML in a news release.

The study found that “marijuana use decreased significantly among working and non-working 8th and 10th graders.” Marijuana use similarly declined among 12th graders who were not employed, while among 12th graders who were employed more than eleven hours per week marijuana use actually increased over the study period, though just slightly. The study’s authors acknowledged that this latter finding was not unexpected because “the workplace may expose adolescents to peer or adult coworkers’ potentially unhealthy behaviors, including substance use.” Authors further acknowledged that working youth were also more likely to have reported using cannabis prior to the passage of legalization.

Continue reading

Study: CBD May be Effective in the Treatment of Painful Diabetic Neuropathy

According to a new study being published by the journal Brain Research, and epublished online by the National Institute of Health,  cannabidiol (CBD) ” may be effective in the treatment of painful diabetic neuropathy “.

“Most diabetic patients describe moderate to severe pain symptoms whose pharmacological treatment is palliative and poorly effective”, states the study’s abstract. “Cannabidiol (CBD) has shown promising results in painful conditions.” With this in mind, researchers “aimed to investigate the potential antinociceptive effect of CBD over the mechanical allodynia in streptozotocin-induced diabetic (DBT) rats, as well as its involved mechanisms.”

For the study, “Wistar adult male diabetic rats were treated acutely or sub-chronically (for 14 days) with CBD (0.1, 0.3 or 3 mg/Kg, intraperitoneal; i.p.) and had their mechanical threshold assessed using the electronic Von Frey. ” Acute treatment with CBD (at doses of 0.3 and 3 mg/Kg) “exerted a significant anti-allodynic effect, which is not associated with locomotor impairment. “The antinociceptive effect of CBD (3 mg/Kg) was not altered by the pre-treatment with CB1 or CB2 receptor antagonists (AM251 and AM630; respectively; both at a dose of 1 mg/kg, i.p.) nor by glycine receptor antagonist (strychnine hydrochloride, 10 μg/rat, intrathecal, i.t.).”

Continue reading